Immunome (IMNM) Profit After Tax (2019 - 2026)
Immunome (IMNM) reported Profit After Tax of -$53.8 million for Q1 2026, down 29.3% on a YoY basis from -$76.1 million in Q1 2025, and up 22.98% quarter-over-quarter from -$69.9 million in Q4 2025.
Immunome (IMNM) Profit After Tax (2019 - 2026) Analysis & Trends
Immunome has reported Profit After Tax for 8 years, with the latest figure at -$53.8 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 29.3% year-over-year to -$53.8 million; the trailing twelve-month figure through Mar 2026 stood at -$224.6 million (down 9.5% YoY), and the FY2025 full-year result was -$212.4 million, up 27.5% from the prior year.
- Profit After Tax for Q1 2026 stood at -$53.8 million, up from -$69.9 million in the prior quarter.
- The five-year high for Profit After Tax was -$4.3 million in Q1 2023, with the low at -$129.5 million in Q1 2024.
- Historically, Profit After Tax has averaged -$41.3 million across 5 years, with a median of -$41.6 million in 2025.
- Annual changes were most pronounced in 2024 — Profit After Tax slumped 2932.6% — and 2025, when it jumped 67.84%.
- Immunome's Profit After Tax stood at -$7.8 million in 2022, then tumbled by 1089.14% to -$92.6 million in 2023, then rose by 13.37% to -$80.2 million in 2024, then rose by 12.9% to -$69.9 million in 2025, then grew by 22.98% to -$53.8 million in 2026.
- The last three Profit After Tax figures came in at -$53.8 million (Q1 2026), -$69.9 million (Q4 2025), and -$57.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | -53.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.84 Mn |
| Dec 31, 2025 | -69.90 Mn |
| Sep 30, 2025 | -57.46 Mn |
| Jun 30, 2025 | -43.40 Mn |
| Mar 31, 2025 | -41.64 Mn |
| Dec 31, 2024 | -80.25 Mn |
| Sep 30, 2024 | -47.10 Mn |
| Jun 30, 2024 | -36.12 Mn |
| Mar 31, 2024 | -129.49 Mn |
| Dec 31, 2023 | -92.63 Mn |
| Sep 30, 2023 | -4.35 Mn |
| Jun 30, 2023 | -5.56 Mn |
| Mar 31, 2023 | -4.27 Mn |
| Dec 31, 2022 | -7.79 Mn |
| Sep 30, 2022 | -8.53 Mn |
| Jun 30, 2022 | -8.92 Mn |
| Mar 31, 2022 | -11.70 Mn |
| Dec 31, 2021 | -7.85 Mn |
| Sep 30, 2021 | -7.72 Mn |
| Jun 30, 2021 | -5.24 Mn |